Controversies in the management of gynecological cancers
著者
書誌事項
Controversies in the management of gynecological cancers
Springer, 2014
- hbk.
- eBook
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Formerly CIP Uk
Includes bibliographical references and index
Also issued online
内容説明・目次
内容説明
This is a novel text that highlights the controversial areas in the management of gynecological cancers. None of the topics in this book have definitive answers; they represent the everyday decision-making facing gynecologists, oncologists, radiologists, pathologists and other health professionals treating women with these conditions. This book is not to be used as a traditional textbook; it is a text that specialists and trainees will use to help them weigh up the arguments that exist in a variety of areas in the treatment of gynecological cancers. Each chapter will have two or more authors, selected either for their opposing views or for their ability to provide an opposite view or opinion to the other. The content will be evidence-based, illustrating contrasting evidence and scientific opinion in the literature. Each chapter will close on a summary indicating the direction of research needed to address the issues being discussed.
目次
1. Controversies in the Treatment of Women with Early Stage Epithelial Ovarian Cancer.- 2. Recurrent Ovarian Cancer: When to Treat and How to Assess.- 3. New Views of Ovarian Carcinoma Types: How will this Change Practice?.- 4. Lymphadenectomy in Endometrial Cancer: The Controversy Rages Unabated.- 5. What is the Role of Adjuvant Radiotherapy and Chemotherapy in Endometrial Cancer?.- 6. Chemotherapy and/or Targeted Therapies for Advanced Endometrial Cancer: Time to Rethink?.- 7. Is Cervix Cancer a Disappearing Disease? Impact of HPV Vaccination in Developed Countries.- 8. What is the Role of Cytotoxic Chemotherapy in Advanced Cervical Cancer?.- 9. Response as a Measure of Treatment Efficacy in Clinical Trials: Should RECIST Be Abandoned?.- 10. What are the Treatment Options for Recurrent Ovarian Cancer?.- 11. How To Study Rare Gynaecological Tumours: Trials or Registries?.- 12. What is the Best Treatment Model for Gynaecological Cancers? Does Centralization Help?.- 13. When Should Surgery be Performed for the First-Line Treatment of Advanced Ovarian Cancer?.- 14. Does Intraperitoneal Therapy for Ovarian Cancer have a Future?.- 15. Maintenance Therapy for First-Line Treatment of Ovarian Cancer-Is this the Strategy for the Future?.- 16. What is the Value of Lymphadenectomy in Early Ovarian Cancer?.- 17. Sentinel Node Biopsy-Does it Help in the Management of Vulvar Cancer?.- 18. Controversies in the Management of Advanced Vulvar Cancer.- 19. Bowel Obstruction in Ovarian Cancer: To Operate or Not?.- 20. Early Cervical Cancer: Can Fertility be Safely Preserved?.- 21. What is the Role of PET/CT in Gynaecologic Cancers?.- 22. Do Intensity-Modulated Radiation, Image-Guided Radiation, and 3D Brachytherapy Significantly Advance Radiotherapeutic Management of Gynecologic Cancers?.- 23. What is the Place of Hormone Replacement Therapy in Ovarian, Endometrial, and Breast Cancer?.- 24. Familial Gynaecological Cancers: Whom to Screen and How to Manage?.- 25. Trial Design: Should Randomized Phase III Trials in Gynaecological Cancers be Abandoned?.- 26. How Should Early Gestational Trophoblastic Disease be Managed?.- 27. Should Every Woman with Gynaecologic Cancer Undergo Routine Screening for Psychological Distress and Sexual Dysfunction?.- 28. How Should Gynaecological Sarcomas be Managed?.- 29. What is the Future of Immunotherapy in Ovarian Cancer?.
「Nielsen BookData」 より